PDSB - PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q2 2021 Results - Earnings Call Transcript
PDS Biotechnology Corporation (PDSB) Q2 2021 Earnings Conference Call August 12, 2021 08:00 AM ET Company Participants Deanne Randolph - VP, Commercial Development & Head, IR Frank Bedu-Addo - President, CEO & Director Lauren Wood - Chief Medical Officer Seth Van Voorhees - CFO, Principal Financial & Accounting Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Leland Gershell - Oppenheimer & Co. Inc. Joseph Pantginis - H.C. Wainwright & Co. Robert LeBoyer - Noble Capital Markets James Molloy - Alliance Global Partners Presentation Operator Greetings and welcome to PDS Biotechnology Second Quarter 2021 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Deanne Randolph, Vice President of Commercial Development. Please go ahead. Deanne Randolph Good morning, and welcome to PDS Biotechnology's second quarter 2021 earnings conference call and audio webcast. With me today are
For further details see:
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q2 2021 Results - Earnings Call Transcript